You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xtandi

Showing 26 - 50 of 165
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • FOR46
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 1, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

Recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Feb 2, 2023

Metastatic Castration Resistant Prostate Cancer Trial in India (Enzalutamide, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ahmedabad, India
  • +7 more
Jan 21, 2023

Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

Recruiting
  • Metastatic Prostate Cancer
  • Badalona, Spain
  • +8 more
Jan 18, 2023

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 5, 2022

Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Bone Metastases
  • Brescia, Italy
    Azienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)

Recruiting
  • Prostate Cancer
  • Washington, District of Columbia
  • +3 more
Jun 1, 2022

Metastatic Castrate-Resistant Prostate Cancer Treated With

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Dec 22, 2020

Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)

Not yet recruiting
  • Prostate Cancer
  • +7 more
  • (no location specified)
Jan 12, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Switzerland, United Kingdom (AZD5069, Enzalutamide 40 MG)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Bellinzona, Switzerland
  • +3 more
Mar 18, 2022

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Prostatic Tumors, Pelvic Nodal Trial in San Francisco (Enzalutamide, Leuprolide, Intensity-Modulated Radiation Therapy)

Terminated
Has Results
  • Prostatic Neoplasms
  • Pelvic Nodal
  • San Francisco, California
    University of California San Francisco
Sep 14, 2021

Prostate Cancer Trial in Ann Arbor, Detroit (ARRx, Enzalutamide)

Suspended
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +1 more
Dec 17, 2021

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Completed
  • Castration-resistant Prostate Cancer
  • Aichi, Japan
  • +46 more
Dec 22, 2020

Prostate Cancer, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma Trial in Baltimore (Ipilimumab, Nivolumab,

Completed
Has Results
  • Prostate Cancer
  • +2 more
  • Ipilimumab
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jan 6, 2022